Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-08-23

Clinical Trial Update: The ACTS Trial: N-acetylcysteine (NAC) and Night-splinting as a Non-operative Treatment for Carpal Tunnel Syndrome [Phase 4]

View source ↗

Summary

The ACTS trial is a Phase 4 study assessing N-acetylcysteine (NAC) with night-splinting as a non-operative treatment for carpal tunnel syndrome; the study is cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Emily Krauss | Conditions: Carpal Tunnel Syndrome, Hand Injuries and Disorders | Phase 4 | Status: RECRUITING